相似文献
1
Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.
Infect Dis Clin North Am. 2004 Dec;18(4):963-74; x-xi. doi: 10.1016/j.idc.2004.07.010.
2
Severe pneumococcal pneumonia: new strategies for management.
Curr Opin Crit Care. 2006 Oct;12(5):470-6. doi: 10.1097/01.ccx.0000244129.69742.d9.
3
Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
J Lab Clin Med. 2004 May;143(5):269-83. doi: 10.1016/j.lab.2004.02.002.
4
Bacteremic pneumococcal pneumonia associated with macrolide failure.
Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):39-42. doi: 10.1007/s10096-005-0081-z.
5
Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia.
Eur J Clin Microbiol Infect Dis. 2006 Aug;25(8):518-21. doi: 10.1007/s10096-006-0183-2.
6
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
Arch Intern Med. 2000 May 22;160(10):1399-408. doi: 10.1001/archinte.160.10.1399.
7
A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
Eur J Intern Med. 2008 Jan;19(1):15-21. doi: 10.1016/j.ejim.2007.03.015. Epub 2007 Sep 19.
8
Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia.
Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):447-51. doi: 10.1007/s10096-007-0307-3.
9
Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis.
J Infect. 2018 Apr;76(4):342-347. doi: 10.1016/j.jinf.2018.01.003. Epub 2018 Jan 31.
10
What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?
Clin Infect Dis. 2003 Feb 15;36(4):396-8. doi: 10.1086/367545. Epub 2003 Jan 31.
引用本文的文献
1
Cilostazol for the prevention of pneumonia: a systematic review.
Pneumonia (Nathan). 2018 Apr 5;10:3. doi: 10.1186/s41479-018-0046-5. eCollection 2018.
2
Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.
Cochrane Database Syst Rev. 2016 Nov 14;11(11):CD005598. doi: 10.1002/14651858.CD005598.pub4.
3
True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants.
Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2639-44. doi: 10.1007/s10096-012-1607-9. Epub 2012 Mar 31.
4
Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G.
Clinics (Sao Paulo). 2011;66(1):95-100. doi: 10.1590/s1807-59322011000100017.
5
Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection.
Clin Infect Dis. 2008 Aug 15;47(4):510-6. doi: 10.1086/590006.
本文引用的文献
1
Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients.
Clin Infect Dis. 2004 May 15;38 Suppl 4:S328-40. doi: 10.1086/382689.
2
Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia?
J Infect Dis. 2004 May 1;189(9):1743. doi: 10.1086/383131.
3
Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.
Crit Care Med. 2004 Mar;32(3):625-31. doi: 10.1097/01.ccm.0000114817.58194.bf.
4
Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia.
J Infect Dis. 2004 Apr 15;189(8):1506-15. doi: 10.1086/382962. Epub 2004 Mar 29.
5
Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.
AMA Arch Intern Med. 1951 Oct;88(4):489-94. doi: 10.1001/archinte.1951.03810100073006.
6
Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.
J Infect Dis. 2004 Feb 15;189(4):711-6. doi: 10.1086/381392. Epub 2004 Jan 30.
7
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.
Clin Infect Dis. 2003 Dec 1;37(11):1405-33. doi: 10.1086/380488. Epub 2003 Nov 3.
8
PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.
Ann Intern Med. 1964 May;60:759-76. doi: 10.7326/0003-4819-60-5-759.
9
ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract.
Infect Immun. 2003 Sep;71(9):4925-35. doi: 10.1128/IAI.71.9.4925-4935.2003.
10
An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.
Clin Infect Dis. 2003 Jul 15;37(2):230-7. doi: 10.1086/377534. Epub 2003 Jul 7.
Zotero 插件